comparemela.com

Tim Guilliams News Today : Breaking News, Live Updates & Top Stories | Vimarsana

US investment boosts Healx in start to transformational 2024

Healx co-founder and CEO Tim Guilliams is predicting a blockbusting 2024 for the Cambridge-based rare disease AI specialist following a major investment boost from the US.

Children s Tumor Foundation invests in Healx to advance Neurofibromatosis Type 1 treatments

Hard pill to swallow A grateful world was only introduced to Viagra because one Welsh ex-miner - and the nurse he confided in - overcame their embarrassment to reveal a startling side effect!

A female nurse clinician overseeing a drug trial in the early 1990s posed a question that she noticed the male volunteers were reluctant to address.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.